FOXP1 and neoplasm: To test this hypothesis, we generated conditional skeletal muscle‐specific FoxP1 over‐expressing mice to determine the sufficiency of FoxP1 to induce muscle wasting and weakness, and through FoxP1 knockdown, further determined the requirement of FoxP1 for the muscle atrophy phenotype induced by tumour burden.